T7	Subject 18 49	three patients with hepatitis C
T8	Treatment 59 82	IFN-alpha and ribavirin
T9	Effect 117 220	two successive phases of silent thyroiditis followed by hyperthryroidism relapse due to Graves' disease
T11	Population 18 23	three
T12	Treat-Disorder 38 49	hepatitis C
T13	Drug 59 68	IFN-alpha
T14	Drug 73 82	ribavirin
T10	Adverse_event 107 116	developed
E1	Adverse_event:T10 
T1	Sub-Disorder 205 220	Graves' disease
